Active, not recruitingPhase 3NCT04901195

A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

Studying Anterior cutaneous nerve entrapment syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
UCB Biopharma SRL
Principal Investigator
UCB Cares
001 844 599 2273
Intervention
Bimekizumab(drug)
Enrollment
658 enrolled
Eligibility
18 years · All sexes
Timeline
20212026

Study locations (30)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04901195 on ClinicalTrials.gov

Other trials for Anterior cutaneous nerve entrapment syndrome

Additional recruiting or active studies for the same condition.

See all trials for Anterior cutaneous nerve entrapment syndrome

← Back to all trials